Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages

April 3, 2012 | Customer News

Tecan granted patent for revolutionary NanoQuant Plate™

The NanoQuant Plate simplifies measurement of low volume samples

Männedorf, Switzerland, April 3, 2012 –
The revolutionary design of Tecan’s NanoQuant Plate™ has been recognized with the granting of a new European patent. Launched in 2008, the NanoQuant Plate was the first solution on the market designed for simultaneous measurement of multiple low volume samples. This innovative device consists of 16 precision-manufactured quartz optics in a user-friendly format, offering precise, straightforward absorbance- and fluorescence-based measurements from sample volumes as low as 2 µl. Combined with Tecan’s Infinite® series readers – the Infinite 200 PRO, Infinite F500 and Infinite M1000 PRO – the NanoQuant Plate provides the ideal solution for DNA or RNA quantification, allowing detection of concentrations down to 1 ng/µl for a wide variety of applications.

To take full advantage of the NanoQuant Plate’s exceptional sensitivity, Tecan has developed the Infinite 200 PRO NanoQuant specifically for absorbance applications with small sample volumes – another industry first. This sensitive plate reader offers the highest spectrometer capabilities, using Tecan’s exceptional Quad4 Monochromators™ or UV-stable filters to cover the entire UV to NIR spectral range, and is available with a range of modules to provide the right solution for your needs.

To find out more about Tecan’s NanoQuant Plate, visit www.tecan.com/nanoquant
 

For more information please contact

Tecan Trading AG
Antonietta Allocca
Seestrasse 103
CH-8708 Männedorf

Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12

info@tecan.com
www.tecan.com


About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).